Literature DB >> 18360285

Host CCL3L1 gene copy number in relation to HIV-1-specific CD4+ and CD8+ T-cell responses and viral load in South African women.

Sharon Shalekoff1, Stephen Meddows-Taylor, Diana B Schramm, Samantha L Donninger, Glenda E Gray, Gayle G Sherman, Ashraf H Coovadia, Louise Kuhn, Caroline T Tiemessen.   

Abstract

HIV-specific T-cell responses play an important role in control of infection. Because CCL3 has immune modulatory and antiviral activities, we hypothesized that host CCL3 genotype (CCL3L1 gene duplications) would influence the development of effective HIV-specific immune responses. Copy numbers of CCL3L1 were determined for 71 HIV-infected women, and HIV-specific CD4 and CD8 T-cell responses to overlapping peptide pools spanning the HIV-1 subtype C genome were simultaneously measured by an interferon-gamma and interleukin-2 whole-blood flow cytometric assay. Host CCL3L1 copy number correlated negatively with viral load (r=-0.239, P=0.045), as did magnitudes of Gag CD4 (r=-0.362, P=0.002) and CD8 (r=-0.261, P=0.028) T-cell responses. Patients with a Gag CD4 response (P=0.002) or dominant Gag CD8 (P=0.006) response had significantly lower viral loads than those whose dominant response targeted another region of the genome, whereas a dominant Nef-specific CD8 T-cell response was associated with higher HIV viral load. CCL3L1 copy number greater than or equal to the population median of 5 was significantly associated with increased magnitude of CD4 Gag responses (P=0.017), and women who had CD4 and CD8 Gag-specific responses had significantly lower viral loads (P=0.004) and higher CCL3L1 copy number (P=0.015) than those women with only CD8 Gag-specific responses.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18360285      PMCID: PMC2562935          DOI: 10.1097/QAI.0b013e31816fdc77

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  59 in total

1.  Higher macrophage inflammatory protein (MIP)-1alpha and MIP-1beta levels from CD8+ T cells are associated with asymptomatic HIV-1 infection.

Authors:  F Cocchi; A L DeVico; R Yarchoan; R Redfield; F Cleghorn; W A Blattner; A Garzino-Demo; S Colombini-Hatch; D Margolis; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

2.  Loss of CD4+ T cell proliferative ability but not loss of human immunodeficiency virus type 1 specificity equates with progression to disease.

Authors:  J D Wilson; N Imami; A Watkins; J Gill; P Hay; B Gazzard; M Westby; F M Gotch
Journal:  J Infect Dis       Date:  2000-08-17       Impact factor: 5.226

3.  Chemokine gene adjuvants can modulate immune responses induced by DNA vaccines.

Authors:  J J Kim; J S Yang; T Dentchev; K Dang; D B Weiner
Journal:  J Interferon Cytokine Res       Date:  2000-05       Impact factor: 2.607

4.  Rapid whole blood analysis of virus-specific CD4 and CD8 T cell responses in persistent HIV infection.

Authors:  M Sester; U Sester; H Köhler; T Schneider; L Deml; R Wagner; N Mueller-Lantzsch; H W Pees; A Meyerhans
Journal:  AIDS       Date:  2000-12-01       Impact factor: 4.177

5.  Comprehensive analysis of human immunodeficiency virus type 1-specific CD4 responses reveals marked immunodominance of gag and nef and the presence of broadly recognized peptides.

Authors:  Daniel E Kaufmann; Paul M Bailey; John Sidney; Bradford Wagner; Philip J Norris; Mary N Johnston; Lisa A Cosimi; Marylyn M Addo; Mathias Lichterfeld; Marcus Altfeld; Nicole Frahm; Christian Brander; Alessandro Sette; Bruce D Walker; Eric S Rosenberg
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

6.  Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection.

Authors:  P Borrow; H Lewicki; B H Hahn; G M Shaw; M B Oldstone
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

7.  Hierarchical targeting of subtype C human immunodeficiency virus type 1 proteins by CD8+ T cells: correlation with viral load.

Authors:  Agatha Masemola; Tumelo Mashishi; Greg Khoury; Phineas Mohube; Pauline Mokgotho; Efthyia Vardas; Mark Colvin; Lynn Zijenah; David Katzenstein; Rosemary Musonda; Susan Allen; Newton Kumwenda; Taha Taha; Glenda Gray; James McIntyre; Salim Abdool Karim; Haynes W Sheppard; Clive M Gray
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

8.  Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics.

Authors:  M R Klein; C A van Baalen; A M Holwerda; S R Kerkhof Garde; R J Bende; I P Keet; J K Eeftinck-Schattenkerk; A D Osterhaus; H Schuitemaker; F Miedema
Journal:  J Exp Med       Date:  1995-04-01       Impact factor: 14.307

9.  Loss of HIV-1-specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4+ T cells.

Authors:  Mathias Lichterfeld; Daniel E Kaufmann; Xu G Yu; Stanley K Mui; Marylyn M Addo; Mary N Johnston; Daniel Cohen; Gregory K Robbins; Eunice Pae; Galit Alter; Alysse Wurcel; David Stone; Eric S Rosenberg; Bruce D Walker; Marcus Altfeld
Journal:  J Exp Med       Date:  2004-09-20       Impact factor: 14.307

10.  Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease.

Authors:  A Carmichael; X Jin; P Sissons; L Borysiewicz
Journal:  J Exp Med       Date:  1993-02-01       Impact factor: 14.307

View more
  22 in total

1.  Natural killer cells that respond to human immunodeficiency virus type 1 (HIV‐1) peptides are associated with control of HIV‐1 infection.

Authors:  Caroline T Tiemessen; Sharon Shalekoff; Stephen Meddows-Taylor; Diana B Schramm; Maria A Papathanasopoulos; Glenda E Gray; Gayle G Sherman; Ashraf H Coovadia; Louise Kuhn
Journal:  J Infect Dis       Date:  2010-11-01       Impact factor: 5.226

Review 2.  Mendelian randomization: potential use of genetics to enable causal inferences regarding HIV-associated biomarkers and outcomes.

Authors:  Weijing He; John Castiblanco; Elizabeth A Walter; Jason F Okulicz; Sunil K Ahuja
Journal:  Curr Opin HIV AIDS       Date:  2010-11       Impact factor: 4.283

3.  Gene copy number: learning to count past two.

Authors:  Sadeep Shrestha; Jianming Tang; Richard A Kaslow
Journal:  Nat Med       Date:  2009-10       Impact factor: 53.440

4.  Single-dose nevirapine exposure affects T cell response and cytokine levels in HIV type 1-infected women.

Authors:  Sharon Shalekoff; Stephen Meddows-Taylor; Diana B Schramm; Glenda Gray; Gayle Sherman; Ashraf Coovadia; Louise Kuhn; Caroline T Tiemessen
Journal:  AIDS Res Hum Retroviruses       Date:  2009-10       Impact factor: 2.205

5.  Identification of human immunodeficiency virus-1 specific CD8+ and CD4+ T cell responses in perinatally-infected infants and their mothers.

Authors:  Sharon Shalekoff; Stephen Meddows-Taylor; Glenda E Gray; Gayle G Sherman; Ashraf H Coovadia; Louise Kuhn; Caroline T Tiemessen
Journal:  AIDS       Date:  2009-04-27       Impact factor: 4.177

6.  A whole genome association study of mother-to-child transmission of HIV in Malawi.

Authors:  Bonnie R Joubert; Ethan M Lange; Nora Franceschini; Victor Mwapasa; Kari E North; Steven R Meshnick
Journal:  Genome Med       Date:  2010-03-01       Impact factor: 11.117

7.  Variations in CCL3L gene cluster sequence and non-specific gene copy numbers.

Authors:  Sadeep Shrestha; Mawuli Nyaku; Jeffrey C Edberg
Journal:  BMC Res Notes       Date:  2010-03-16

8.  Combinatorial content of CCL3L and CCL4L gene copy numbers influence HIV-AIDS susceptibility in Ukrainian children.

Authors:  Ludmila Shostakovich-Koretskaya; Gabriel Catano; Zoya A Chykarenko; Weijing He; German Gornalusse; Srinivas Mummidi; Racquel Sanchez; Matthew J Dolan; Seema S Ahuja; Robert A Clark; Hemant Kulkarni; Sunil K Ahuja
Journal:  AIDS       Date:  2009-03-27       Impact factor: 4.177

9.  CCL3L1 copy number is a strong genetic determinant of HIV seropositivity in Caucasian intravenous drug users.

Authors:  Kristi Huik; Maarja Sadam; Tõnis Karki; Radko Avi; Tõnu Krispin; Piret Paap; Kristi Rüütel; Anneli Uusküla; Ave Talu; Katri Abel-Ollo; Irja Lutsar
Journal:  J Infect Dis       Date:  2010-03       Impact factor: 5.226

10.  CCL3L Copy number variation and the co-evolution of primate and viral genomes.

Authors:  German Gornalusse; Srinivas Mummidi; Weijing He; Guido Silvestri; Mike Bamshad; Sunil K Ahuja
Journal:  PLoS Genet       Date:  2009-01-30       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.